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Accurate quantification of heartbeats in fish models is an important readout to study cardiovascular 
biology, disease states and pharmacology. However, dependence on anaesthesia, laborious sample 
orientation or requirement for fluorescent reporters have hampered the use of high-throughput 
heartbeat analysis. To overcome these limitations, we established an efficient screening assay 
employing automated label-free heart rate determination of randomly oriented, non-anesthetized 
medaka (Oryzias latipes) and zebrafish (Danio rerio) embryos in microtiter plates. Automatically 
acquired bright-field data feeds into an easy-to-use HeartBeat software with graphical user interface 
for automated quantification of heart rate and rhythm. Sensitivity of the assay was demonstrated by 
profiling heart rates during entire embryonic development. Our analysis revealed rapid adaption of 
heart rates to temperature changes, which has implications for standardization of experimental layout. 
The assay allows scoring of multiple embryos per well enabling a throughput of >500 embryos per 96-
well plate. In a proof of principle screen for compound testing, we captured concentration-dependent 
effects of nifedipine and terfenadine over time. Our novel assay permits large-scale applications ranging 
from phenotypic screening, interrogation of gene functions to cardiovascular drug development.
Quantification of heartbeats is an important readout to study physiology and disease states of the heart. The rest-
ing heart rate (beats per minute, bpm) is a strong predictive risk factor of overall mortality and associated with 
a growing catalogue of genetic variants and environmental-sensitive alleles1,2. However, geneticists are facing an 
enormous challenge to establish causality for associated candidate variants. Small fish models provide efficient 
means of functional assessment in the context of a vertebrate. In fish models heart rate and rhythm quantification 
is employed for analysing inherited or acquired arrhythmia3, for validation of genetic variants4, phenotypic drug 
discovery and safety pipelines5 or for toxicological studies6. Moreover, the recent establishment of a vertebrate 
panel of isogenic strains in medaka fish enables to study variations of quantitative traits such as heart rate in 
genome-wide association studies7. However, there is a lack of efficient screening workflows that allow large-scale 
quantitative scoring of cardiac phenotypes. Therefore, novel and efficient protocols were needed encompassing 
sample preparation, automated imaging and image analysis.
The fish species medaka (Oryzias latipes) and zebrafish (Danio rerio) emerged as major vertebrate models 
for phenotypic screening, follow-up functional studies, reverse genetics and for studying human pathologies 
in mechanistic details8,9. Medaka and zebrafish have tractable diploid genomes, feature a short generation time 
(2–3 months), external embryonic development and established protocols for transgenesis and manipulation of 
gene function including CRISPR/Cas-based approaches10,11. Economic husbandry and small transparent embryos 
are particularly suited for large-scale screening and detailed imaging12,13. In both fish species, rapid cardiovascular 
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development leads to a functional cardiovascular system emerging by around 24 hours post fertilization (hpf) in 
zebrafish14 and approximately 48 hpf in medaka15. Although the fish heart is two-chambered, its development and 
function are very similar to the mammalian heart16. Strikingly, components of the electrocardiogram of zebrafish 
and medaka have more similarities to those in humans than have those of rodents, making them ideal models to 
investigate heart rate and rhythm phenotypes and leverage these properties for drug screens17–19. In contrast to mam-
malian models, early zebrafish embryos are sufficiently supplied by oxygen diffusion allowing the study of severe 
cardiovascular and dysfunctional haemoglobin phenotypes that result in embryonic lethality in mammals20.
Readouts of heart rate and rhythm have been employed increasingly in zebrafish- and medaka-based 
screens21–28. Challenges of current methods to capture heart rate in high-throughput include: (i) immobilisation 
of dechorionated embryos or hatchlings, which in the majority of cases is achieved by anaesthesia with tricaine 
leading to severe adverse cardiovascular effects29, (ii) imaging of larvae in standardized orientations, involving 
labour-intensive manual mounting on dedicated sample carriers or embedding in low-melting agarose, (iii) flu-
orescent reporter readouts, which preclude studies of specific genetic backgrounds and (iv) lack of user-friendly 
software for efficient analysis of multiple hearts simultaneously.
We therefore developed a high-throughput screening pipeline with simple sample handling and fully auto-
mated imaging of unhatched medaka and zebrafish embryos. Label-free imaging can be performed under physio-
logical conditions and controlled temperature without anaesthesia or agarose-based mounting, and with scalable 
numbers of embryos per plate. The screening workflow is complemented by a user-friendly open-access soft-
ware package, named HeartBeat, for robust quantification of heart rate and rhythm. Applied to both zebrafish 
and medaka we quantified native heart rate throughout development from heartbeat onset to hatching stage. To 
facilitate high-throughput applications, microplates containing up to 6 embryos per well were scored with high 
success rates and reliability. Additionally, we studied cardiac activity responses to temperature ramps enabling the 
analysis of physical stress response or profiling temperature-sensitive mutants. As a proof of concept for pharma-
cological screens, we tested nifedipine and terfenadine resulting in heart rate inhibition. This demonstrates the 
applicability to preclinical drug screens and toxicological tests using fish models.
Results
High-throughput assay and HeartBeat software. We implemented a rapid workflow for automated 
imaging of medaka and zebrafish embryos and a new HeartBeat software for extraction of heart rate and rhythm. 
The multi-step pipeline is schematically summarized in Fig. 1. The transparent chorion naturally constrains 
embryonic movement and therefore supersedes anaesthesia or immobilisation. This allows simple sample 
preparation and high-throughput cardiac imaging in a physiological environment. Different speed of embry-
onic development of both fish species can be leveraged for heartbeat time-lapse imaging with different interval 
lengths ranging between ~24–72 hpf in zebrafish and ~2–7 dpf in medaka (Fig. 1a). Single or multiple unhatched 
embryos were analysed without requirements for positioning, orientation or special mounting medium. We used 
96 well-plates as default but also other formats are compatible with the HeartBeat software. U-bottom plates are 
recommended for single embryos per well and F-bottom shapes for multiple embryos per well. A crucial feature 
of the imaging setup is a stationary plate holder combined with moving optics that eliminate plate movement 
artefacts and thus obviating mounting media with high viscosity (Fig. 1b). Processing with HeartBeat is com-
patible with a wide range of sampling rates, resolutions and illumination modes. Here, default settings for heart 
rate scoring were 13 fps with 2x detection objective (whole-well detection) and bright-field (Fig. 1b). For exact 
assessment of beat-to-beat variability, higher frame rates are recommended (see HeartBeat software).
Whole embryo image sequences are processed by three consecutive operations: (i) segmentation based on 
cumulative grey value differences in the input image sequence, smoothing and thresholding, (ii) feature extrac-
tion by calculating the standard deviation (s.d.) in identified segments over time, (iii) spectral analysis and clas-
sification of heart regions. Dialogue windows ask to specify a range of image sequences in a parent directory 
and the numbers of embryos contained in each well. Different numbers of fish to be analysed can be defined for 
multi-mounted wells. In a graphical user interface (GUI), processed time sequences and segments of classified 
heart regions (blue area) and s.d. traces are presented (Fig. 2a,c) and central settings can be navigated (Fig. 2b). 
Thus, visualization of segmentation and classified heartbeats over time allow for rapid quality check and adjust-
ments. For each image sequence, detailed result files are saved as spreadsheets as well as a graphical overview of 
the segmentation (Fig. 2c). Heartrates of all wells are saved in one summary spreadsheet together with a heatmap 
in the corresponding parent directory of the dataset. In a sample of myl7::eGFP embryos acquired both in eGFP 
and BF channels, HR was scoreable in 100% in the GFP channel and 98.9% in bright-field (n = 92 embryos, data 
not shown). Heart rate scores inferred from both channels were highly correlated (Pearson correlation coefficient 
r = 0.98 for manual count vs. software readout in BF and r = 0.95 for software readout in GFP vs. software readout 
in BF; Supplementary Fig. S1). In summary, automated heart rate measurements on whole embryo BF images 
equally perform compared to readout of fluorescently labelled hearts.
Heartbeat detection of multiple embryos per well. Upscaling the number of embryos per plate 
can significantly increase throughput for large-scale applications as more specimen can be assayed in a single 
microplate-wide recording. One option used in some whole-organism screening assays are 384 well plates, that 
would likewise be compatible with the analytical workflow presented in this study. However, parallel captur-
ing of multiple embryos in a single image, additionally reduces the demand for data storage as well as time of 
imaging and analysis. For increased throughput, simultaneous readout of multiple fish hearts per imaging field 
was implemented in the HeartBeat algorithm. To assess conditions and efficiency of parallel readout in single 
wells, an experimental series of 1–6 and 10 embryos per well of 96-well plates were performed for medaka and 
zebrafish (Fig. 3a,b, respectively). Full-size image frames were used to analyse multiple embryos with random 
well positions to achieve correct scoring. Pairwise comparisons of the mean heart rate of mounting groups with 
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≥2 embryos per well to the reference of 1 embryo per well, yielded for medaka a statistically significant elevation 
of heart rates in mounts with 2–6 embryos per well and a formally not significant difference for 10 embryos per 
well. However, increasing variance and numbers of outliers were observed in wells containing 10 embryos. The 
equivalent zebrafish experiment (Fig. 3b) revealed a higher baseline variability, whereas comparisons to the 1 
embryo per well group did not reach statistical significance. A replicate of the experiment for medaka and zebraf-
ish revealed similar results (data not shown). Different offsets of heart rates depending on the number of embryos 
per well can be controlled by using the same numbers of embryos per well for the entire plate. However, as 10 
embryos per well could be scored less effective and yielded an increased number of outliers, a maximum through-
put of 6 embryos per well is most efficient and stable. Taken together, the heart rate workflow presented here can 
be scaled up to 6 embryos per well. For comparability, all wells should be filled with the same number of embryos.
Heart rate dynamics in medaka and zebrafish development. We applied the assay to score heart 
rates during the entire development of medaka and zebrafish embryos. Onset of heartbeat varied in the two fish 
species with earliest heartbeats appearing after 22 hpf in zebrafish and 40 hpf in medaka. From this time points 
onwards, image data was captured every 4 h (Fig. 4). In medaka, embryonic heart rate was rapidly increasing over 
developmental time and started to oscillate in a day-night rhythm from 72 hpf onwards and reached approxi-
mately 175 bpm (at 28 °C) around hatching stage (7 dpf, Fig. 4a). Similarly, after onset of heartbeat in zebrafish, 
heart rate increased and plateaued at around 210 bpm (28 °C, 72 hpf; Fig. 4b). Zebrafish heart rate did not exhibit 
a day-night dependent fluctuation during the period of analysis (22–62 hpf).
Temperature-dependent modulation of heart rate. Ambient temperature is a critical environmental factor 
affecting heart rate in most teleosts. To quantify this effect, we studied the influence of ambient temperature changes 
on heart rate between 26–30 °C (Fig. 5). Heart rates, both in medaka and zebrafish, accelerated significantly per 1 °C 
increase of temperature. This finding underlines the importance of tight temperature control when assessing any heart-
beat related cardiac phenotypes. The influence of the sampling rate on the assay sensitivity was further tested. Medaka 
and zebrafish heart rate quantification on a 30 fps data set and derived synthetic 15 fps data yielded comparable results 
(Supplementary Fig. S3). Moreover, an extended temperature range (21–35 °C) was measured, revealing anticipated 
prominent increases of embryonic heart rates in medaka and zebrafish, which could be used as a simple assay to study 
the mechanisms of genotype × environment interactions (Supplementary Fig. S4).
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Figure 1. Workflow of automated imaging and heart rate quantification in medaka and zebrafish embryos. (a) 
Cardiovascular development is functional after 24 and 48 hpf and hatching occurs around 48–72 hpf and 7–8 
dpf in zebrafish and medaka, accordingly, defining time windows of embryonic cardiac imaging in both fish 
species. (b) Single or multiple fish embryos per well are mounted without anaesthesia or agarose into microtiter 
plates, which have a fixed position in the imaging platform; image sequences can be sampled at different frame 
rates, resolutions and channels; all images were recorded with 2x objective, images with single embryos were 
cropped, multiple embryos in a well (Multi) are presented as full frame; in the fluorescent image A and V denote 
atrium and ventricle and a rough outline of the embryo is overlaid as a reference. (c) After image optimization, 
image sequences are quantified through a GUI of the HeartBeat program (compare Fig. 2) and heart rates, beat-
to-beat variability and an overview of segmentation are saved as spreadsheet and graphical output, respectively.
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Compound effects on heart rate of unhatched medaka and zebrafish embryos. Heart rate is 
frequently scored in preclinical screening assays of chemical compounds employing small fish models. To demon-
strate the compatibility of our platform with high-throughput chemical screening, we trialled two pharmaceu-
ticals, nifedipine and terfenadine, with known inhibitory effects on heart rate in fish5,30. In one 96-well plate, 
groups of 12 embryos were exposed to terfenadine and nifedipine each at 10, 30 and 100 µM. An internal plate 
control was kept in embryo medium (EMR/E3). After a baseline measurement, embryos were incubated in the 
Figure 2. Functionalities of HeartBeat software. (a–c) Graphical user interface of the HeartBeat software 
for computer-assisted semi-automated analysis allowing convenient and rapid quality check. (a) Standard 
deviations of pixel values relating to segmented heart regions are displayed over time in the left panel, where 
heartbeats are indicated by red asterisks for each image sequence. (b) A control panel allows (1) to refine 
settings of segmentation and to choose alternative segments, (2) to re-play the current image sequence 
(visualized in c), (3) to reset all settings or to save heart rates to spreadsheets together with a picture of 
segmented image sequence. (c) Visualization of the image sequence with segmented heart regions displayed as 
numbered blue areas (detailed manual available together with software in Supplementary material online).
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Figure 3. Heartbeat detection of multiple embryos per well. (a,b) Scoring of heart rate with 1–6 and 10 
embryos per well for medaka at 102 hpf (a) and zebrafish at 34 hpf (b). Data is provided as box plots and scatter 
plots of original heart rate measurements. Heart rates of mounting groups with ≥2 embryos per well were each 
tested with Student’s t-test against 1 embryo per well (dashed line indicates mean heart rate of the group with 
1 embryo per well); significant differences are indicated with *P < 0.05, **P < 0.01 and ***P < 0.001, ns (not 
significant); n for each group is indicated in the figure.
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test and vehicle control (0.2% DMSO) solutions for 2 h and captured in 30 min intervals. For each heart rate data 
set of one microtiter plate, the HeartBeat software generates heatmaps for immediate intuitive assessment of drug 
effects; examples are shown at 90 min drug incubation (Fig. 6). Terfenadine elicited significant inhibition of heart 
rate at 100 µM both in medaka and zebrafish although with different dynamics. In medaka, 100 µM terfenadine 
induced a significant reduction of heart rate after 60 min treatment, which became more pronounced over time 
(Fig. 7a). It induced 2:1 atrioventricular (AV) block in some medaka embryos at 90 min and increasingly after 
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Figure 4. Heart rates of medaka and zebrafish during embryonic development. (a,b) Heart rates of unhatched 
embryos were measured from onset of heartbeat until hatching (details in Methods). (a) Circadian oscillation of 
heart rate in medaka from 3 dpf onwards (mean ± s.d., n = 13–18 each point in time). (b) In zebrafish, the onset 
of the heartbeat was followed by an immediate increase of heart rate passing into a less steep slope of increase at 
around 210 bpm (mean ± s.d., n = 12–52 each point in time).
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Figure 5. Temperature-dependent heart rate modulation. (a,b) Heart rate response to temperature gradients 
in medaka (100–102 hpf, n = 47–48 at each temperature in a) and zebrafish (31–33 hpf, n = 43–48 at each 
temperature in b) recorded at 13 fps. Significant differences between heart rates at each temperature were tested 
with one-way ANOVA and pairwise comparisons using Student’s t-test and are given with *P < 0.05, **P < 0.01 
and ***P < 0.001 (significant differences are indicated only for 1 °C-increments; P-values for all pairs of 
combinations in a,b are given in Supplementary Table S1 and S2, respectively); data is presented as box plots 
(median±interquartile range) and overlaid scatter plots of heart rate values.
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120 min drug exposure (Supplementary Video S1). In zebrafish embryos, 100 µM terfenadine suppressed heart 
rate earlier (30 min) and more markedly after 2 h incubation with a transient 2:1 AV block between 30–60 min 
resulting in dual-chamber suppression at 90 min onwards (Fig. 7b, Supplementary Video S2). The HeartBeat soft-
ware extracts either atrial or ventricular beating rate, which is equal in the regularly beating heart. The random 
orientation of the embryos primarily influences whether the heart rate is measured on the atrium or the ventri-
cle. Although the current HeartBeat software version does not measure chamber-specific rates, the AV block of 
terfenadine-treated embryos is nevertheless reflected by atrial rates or ventricular rates (the latter is 50% reduced) 
clustering to the upper or lower quartiles of the box plots, respectively (Fig. 7a, 100 µM terfenadine at 90 min and 
120 min for medaka; Fig. 7b, 100 µM terfenadine at 30 min and 60 min for zebrafish). Nifedipine inhibited heart 
rates in medaka embryos equally at 10, 30 and 100 µM with rapid onset (Fig. 7a). In zebrafish embryos, heart 
rates were decreased by nifedipine in a concentration- and time-dependent manner resulting in asystole for the 
majority of embryos treated with 100 µM nifedipine for 120 min (Fig. 7b). To provide a reference for embryonic 
applications using DMSO carrier, heart rates were assessed for a concentration range of 0.2–1%. In medaka, heart 
rates were not significantly affected by different DMSO concentrations within 2 h of incubation, whereas minor 
heart rate fluctuations occurred at lower DMSO concentrations in zebrafish (Supplementary Fig. S2). As a control 
for stage-dependent changes of heart rate, all measurements (drugs and DMSO) were normalized to a negative 
control group of age-matched untreated embryos (Fig. 7 and Supplementary Fig. S2).
Discussion
Heart rate is a key parameter in numerous small fish model applications including genetics and pharmacology 
and a reliable metric for environmental studies assessing cardiotoxic and adverse developmental effects of small 
molecules and pollutants. Here, we present a physiological assay and open-access HeartBeat software for rapid 
quantitative assessment of heart rate and rhythm of medaka and zebrafish embryos with high analytical power in 
terms of precision and throughput that permits large-scale phenotypic scoring. The commercial imaging system 
used in this study provides an ideal platform with out of the box fulfilment of the imaging requirements, such as 
tight temperature control and non-moving specimen, thus allowing a rapid and highly-efficient implementation 
of the methodology. However, the core method is compatible with many other imaging modalities, including 
more cost-effective open hardware solutions for automated imaging31. The performance of our pipeline allowed 
to capture concentration-dependent effects of cardiovascular active drugs with high temporal resolution.
Our assay overcomes laborious manual mounting and orientation of samples, motion artefacts, confound-
ing effects of anaesthesia and dependency on fluorescent reporters. Fast and reliable quantification of heart rate 
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Figure 6. Quantification of heart rates in fish embryos treated with compounds. 96-well format for incubation 
of medaka and zebrafish embryos with terfenadine and nifedipine each at three different concentrations in µM. 
As a control for stage-dependent changes of heart rate, all measurements (drugs and DMSO) were normalized 
to a negative control group of age-matched untreated embryos (row H). The HeartBeat software directly 
provides a heatmap output for intuitive assessment of drug effects (heart rate response shown at 90 min; nd: not 
detected).
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Figure 7. Heart rate inhibition by nifedipine and terfenadine over time. (a) Time course of drug effects 
revealing heart rate inhibition in medaka embryos (102–104 hpf) by nifedipine and 100 µM terfenadine 
(n = 11–12 each for DMSO, terfenadine 10/30/100 µM, nifedipine 10/30/100 µM at every time point). 
(b) Concentration-dependent heart rate decrease by nifedipine and terfenadine in zebrafish (32–34 hpf; 
n = 10–12 for all treatment and control groups at every time point). Significant difference between each drug 
concentration and the time-matched DMSO control group were tested with one-way ANOVA and pairwise 
comparisons using Student’s t-test and are given with *P < 0.05, **P < 0.01 and ***P < 0.001, ns (not 
significant); data is visualized as box plots (median ± interquartile range) and scatter plots of original data 
points. At all points in time, each heart rate measurement of one of the treatment groups is normalized to the 
mean heart rate of a control group in fish medium (ERM/medaka, E3/zebrafish; data not shown) to account for 
stage-dependent changes and is expressed relative to the corresponding baseline treatment group mean (time 
point 0).
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is achieved by combining automated image acquisition of unhatched, randomly oriented fish embryos with 
software-based segmentation of heart regions and automatic heartbeat detection. Precise temperature control 
during automated imaging ensures reproducibility and cross-centre data comparability. The HeartBeat software 
was developed for user-independent, automatic segmentation of heart regions and feature extraction of rate and 
rhythmicity with high reliability and reproducibility. A GUI provides non-expert user swift computer-assisted 
analysis with control of key settings and visualization of analytic output. This interface minimizes user bias and 
permits to set standards for data comparability between experiments and research groups. A compiled version 
of the software can be executed with freely available MATLAB Runtime. Of note, heartbeat quantification can be 
performed robustly on bright-field image sequences with comparable efficiency to image sequences with labelled 
hearts. The analysis in bright-field mode is critical for rapid screening of multiple wild-type strains without flu-
orescent reporters. The software is compatible with many imaging setups with manual or automated record-
ing using different magnifications. We chose a sampling rate of 13 Hz sufficient for frequencies of heartbeats in 
medaka and zebrafish embryos. Maximal heart rates at 35 °C were 278.6 bpm (4.62 Hz) and 325 bpm (5.42 Hz) 
in medaka and zebrafish, respectively (Fig. 5). At 28 °C, average heart rates were at 163 bpm (2.72 Hz, medaka) 
and 197 bpm (3.28 Hz, zebrafish; Fig. 5). For analysis of beat-to-beat intervals, however, we recommend sampling 
at higher frame rates. These frame rates are compatible with standard microscopy equipment. Together with the 
HeartBeat software we provide scripts for file parsing and image optimization, which can be adapted to individual 
setups and data handling. Cropping to single embryos increased performance, further improved scoring success 
by eliminating spurious background signals in a storage space efficient manner. TIFF and JPEG compressed 
image sequences are equally compatible with the HeartBeat software. The compatibility with compressed image 
data massively reduces data volumes, thus facilitating the data transfer across remote collaborators.
To explore the maximal throughput, HeartBeat software was applied to readout multiple fish per well and reli-
ably captured heart rates of up to 10 embryos per well. Differences between mean heart rates extracted from wells 
with different embryo densities (Fig. 3) might be reflecting varying physiological environments. For comparative 
assays this needs to be controlled by using the same numbers of embryos per well for the entire plate. Automated 
capturing of multiple hearts was performed most efficiently up to 6 embryos per well resulting in >500 embryos 
processed per 96-well plate, particularly suitable for drug screening pipelines.
To date, several methods have been used to assess heartbeat in zebrafish hatchlings, medaka embryos, fish 
species, Drosophila, cardiomyocytes or mouse embryos21,22,24,25,27,28,32–36. Some of these methods require trans-
genic embryos with fluorescent cardiomyocytes or erythrocytes to measure heartbeats26,32. Other approaches 
depend on advanced microscopes such as confocal laser scanning microscope26 or dual-beam optical reflec-
tometer34, imaging modalities that may affect sample temperature and confounding effects on heart rate (Fig. 5). 
Another caveat is immobilisation of fish larvae in low-melting agarose to achieve specific orientations, which is 
time-consuming and complicates genuine high-throughput assays. Some methods were restricted to a narrow 
time window of newly hatched zebrafish prior to swim bladder inflation to avoid movements of the larvae during 
sampling28,32. In addition, larvae were acclimatized to the illumination of the well scans. To achieve stable imag-
ing condition many protocols rely on anesthesia21,22,24,27,33. The most widely used anaesthetic is tricaine (MS-222, 
ethyl 3-aminobenzoate methanesulfonate), that affects cardiovascular functions including heart rate and contrac-
tility37,38. Our assay, on the other hand, relies on recording non-anesthetized unhatched medaka and zebrafish 
embryos in their natural environment within the chorion allowing fast sample distribution into microtiter plate, 
and is compatible with robotic handling of fish embryos in systematic screens39,40.
We demonstrate robust heart rate quantification of randomly positioned and oriented fish embryos and imple-
mented options in the HeartBeat GUI to easily improve the accuracy of heartbeat detection, such as changing the 
threshold of detection, if necessary. Full 96-well plates are imaged in 20 min with 10 s videos at 13 fps for each 
well. High-confidence quantification can be performed within 45–60 min. In the meantime, our reliable and effi-
cient assay permitted us to automatically quantify heart rate of more than 20 000 image sequences corresponding 
to approximately 20 TB of data.
While only scant data of embryonic medaka heart rate was available15, using the HeartBeat assay we now pro-
vide a systematic profile as reference for future studies (Fig. 4a). Interestingly, after 3 days of development heart 
rate in medaka showed day-night undulation with a nocturnal dipping resembling the circadian heart rate pat-
terns in healthy humans41. Zebrafish has faster embryogenesis and morphological differentiation including loop-
ing of the heart is completed by 36 hpf42. Serial recordings from onset of heartbeat onwards reliably delineated the 
rapid increase of heart rate associated with major steps of cardiac development within the first 2.5 dpf (Fig. 4b). 
As aerobic capacity and metabolic rate are directly interrelated with ambient temperature, incremental warm-
ing (Fig. 5 and Supplementary Fig. S4) can be applied as physical stressor in ectothermic medaka and zebrafish 
embryos, which regulate cardiac output in response to temperature primarily through adaption of heart rate 
rather than stroke volume43,44. Tight control of heart rate by temperature can be leveraged as readout of acute and 
chronic adaptive stress responses, temperature-sensitive strains45 and of susceptibility to arrhythmia in strains 
with different genetic backgrounds. In summary, our detailed analysis stresses the importance to rigorously con-
trol temperature and normalize to stage-dependent changes of beat rates to ensure experimental standardization.
Medaka and zebrafish embryos are mostly transparent around the heart region, providing ideal conditions for 
direct microscopic observation of the beating heart. Heart rate is a suitable metric to efficiently assess therapeu-
tic and adverse actions of drugs as demonstrated by previous reports using zebrafish hatchlings32. To assess the 
applicability of our assay based on non-hatched embryos for compound treatment and to benchmark the analysis 
software, we designed proof-of-concept experiments using nifedipine and terfenadine. Concentration-dependent 
heart rate inhibition and dynamic changes of drug effects were recorded in a 2 h time-lapse experiment, reliably 
correlating with published negative chronotropic effects of terfenadine and nifedipine in zebrafish5,30. In human, 
the antihistamine terfenadine can induce adverse prolongation of QT interval resulting in increased risk for 
torsades de pointes tachycardia. Detailed studies have demonstrated QT prolongation resulting in AV block in 
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zebrafish46 and medaka45. Probing effects of terfenadine on zebrafish and medaka embryonic heart rate, distinct 
time points of induction and time courses of AV block were uncovered by our assay (Fig. 7). In zebrafish, nifed-
ipine suppresses cardiac Ca2+ channels resulting in a marked decrease of heart rate30,47. This drug action was 
reliably monitored with our assay showing significant effects ranging from sustained inhibition to asystole over 
time (Fig. 7). However, for genuine screening in drug discovery applications, substance-specific effective concen-
trations and bioavailability need to be considered for the experimental design and precisely controlled under par-
ticular technical conditions. Taken together, this proof of concept pharmacological experiment in combination 
with the scalability of our assay raises the prospect of accelerating drug discovery pipelines and rapid pre-clinical 
prediction of adverse drug effects.
In summary, by combining ease and stability of imaging acquisition with software-assisted analysis our 
method offers a comprehensive platform for forward and reverse genetics, gene x environment interaction stud-
ies, pharmaceutical screens and toxicological assessment, which can efficiently direct downstream studies on 
mechanistical details of heart rate related phenotypes.
Methods
Fish husbandry and transgenic line. The inbred, isogenic medaka strain Cab and wild type zebrafish AB 
were kept in closed stocks at the Institute of Biological and Chemical Systems, Biological Information Processing 
(IBCS-BIP) at the Karlsruhe Institute of Technology (KIT) and the Centre for Organismal Studies (COS) at 
Heidelberg University as previously described48,49. Fish husbandry was performed in accordance with EU direc-
tive 2010/63/EU guidelines as well as with German animal protection regulations (Tierschutzgesetz §11, Abs. 1, 
no. 1; Regierungspräsidium Karlsruhe, Germany; husbandry permits AZ35-9185.64/BH KIT and AZ35-9185.64/
BH Wittbrodt). The fish facilities are under the supervision of the Regierungspräsidium Karlsruhe, who approved 
the experimental procedures. Embryos were raised at 28 °C. Embryonic stages are indicated in hours post fertili-
zation (hpf) or days post fertilization (dpf)15,50.
For fluorescent cardiac imaging in medaka, a transgenic line myl7::eGFP was generated. A modified plasmid 
pDestTol2CG (http://tol2kit.genetics.utah.edu/index.php/PDestTol2CG) containing a myl7::eGFP cassette was 
co-injected with Tol2 transposase mRNA into Cab embryos as described51.
Sample preparation and time-lapse experiments. One day prior to imaging medaka eggs were opti-
cally cleared by rolling the eggs on sandpaper (P1000). One hour before imaging, medaka and zebrafish embryos 
were transferred from methylene blue-containing medium into plain ERM and E3, respectively. Single medaka/
zebrafish embryos were mounted with 150 µl ERM/E3 per well in transparent round (U) bottom 96-well plates 
(Thermo Fisher Scientific, 268152) using Cell-Saver tips (Biozym). Multi-mounts (≥ 2 embryos/well) were pre-
pared with 300 µl ERM/E3 per well using flat (F) bottom 96-well plates (Greiner, 655101).
For time-lapse heart rate measurements microtiter plates were kept between 08:00–20:00 in the incubator at 
28 °C and transferred to the microscope with 15 min equilibration time before acquiring two loops at 12:00 and 
16:00. During night cycle the plate remained in the microscope (constant 28 °C) and 4 loops were recorded with 
4 h intervals between 20:00–08:00. For all other experiments, medaka embryos were imaged at day 4 post fertili-
zation (start of recordings at 100–104 hpf) and zebrafish embryos at 1.5 days post fertilization (start of recordings 
at 32–36 hpf) as indicated for each experiment.
Solutions and drug administration. Terfenadine and nifedipine (Sigma, Steinheim, Germany) were pre-
pared as 50 mM stock solutions in dimethylsulphoxide (DMSO) and stored at −20 °C. Prior to application, stock 
solutions were diluted in ERM (medaka) or E3 (zebrafish) to the desired final concentrations; light-sensitive 
nifedipine was prepared freshly for each experiment. DMSO (vehicle control) and drug incubation experiments 
were performed with single mounted embryos. For each plate a baseline was recorded in ERM/E3 at 28 °C (see 
automated microscopy) followed by exchange of the medium with test substances. Prior to the first loop of imag-
ing during drug incubation, embryos were allowed to equilibrate in the incubation chamber of the microscope for 
min. 15 min to max. 30 min after drug transfer to the plate (equals first point in time).
Automated microscopy. 96-well microtiter plates containing zebrafish or medaka embryos were sealed 
with gas-permeable adhesive foil (4titude, Wotton, UK, 4ti-0516/96). After equilibration for 15 min in the incu-
bation chamber of the microscope under bright-field illumination, the plates were automatically imaged on an 
ACQUIFER Imaging Machine, a wide-field high content screening microscope equipped with a white LED array 
for bright-field imaging, a LED fluorescence excitation light source, a sCMOS (2048 × 2048 pixel) camera, a 
stationary plate holder, movable optics and a temperature-controlled incubation lid (DITABIS AG, Pforzheim, 
Germany). The focal plane was detected in the bright-field channel using a software autofocus algorithm. Images 
were acquired using 130 z-slices (dz = 0 µm) with a 2× Plan UW N.A. 0.06 (Nikon, Düsseldorf, Germany) leading 
to the acquisition of a 10 s movie with 13 fps at the very same z-axis position that is determined by the built-in 
software autofocus. Integration times were fixed with 80% relative LED intensity in bright-field and 100% in 
GFP-channel with 10 ms exposure time, generating image sequences of entire microwells of approximately 10 s 
with 13 fps. Capturing an entire 96-well plate generates 12480 frames resulting in 97.5 GB for full camera sensor 
readout size. Each microtiter plate was imaged once at 26 °C, 27 °C, 28 °C, 29 °C, and 30 °C or with the indicated 
time-lapse in case of drug exposures.
HeartBeat detection and analysis software. Image optimization was performed prior to the heart rate 
analysis (Supplementary material online). Based on previous expertise25, a new HeartBeat software was developed 
in MATLAB (Mathworks) for embryonic heart rate quantification and segmentation of multiple hearts in a field 
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of view. The HeartBeat software features a graphical user interface (GUI) for direct application by non-expert 
users (detailed instructions for operation see Supplementary material online). It is executable with MATLAB 
runtime (MATLAB 2017) on a Windows computer and available through https://osf.io/kygd4/. We recommend 
sufficient main memory (≥16 GB RAM) and a solid-state disk hard drive or other storage solution with high I/O 
rates.
Data analysis and statistics. Statistical analyses were computed in R language52 and data visualized using 
the ggplot2 package53. Differences between samples were tested with Student’s t-test and statistical significance 
accepted at a threshold of P < 0.05. Multiple comparisons were tested with one-way ANOVA and significant 
results (P < 0.05) were analysed with pairwise comparisons using Student’s t-test applying significance lev-
els adjusted with the Bonferroni method. Significant P-values are indicated with asterisks (*) with *P < 0.05, 
**P < 0.01 and ***P < 0.001. Correlation analysis was performed using Pearson’s correlation.
Data and Code availability
The HeartBeat analysis software and supporting scripts are available through https://osf.io/kygd4/ in open access. 
Datasets supporting the findings of this study will be provided as spreadsheets by the corresponding authors upon 
request.
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